Prerpints.org logo
Preprint
Article

Toxicological Response of Zebrafish Exposed to Cocktails of Polymeric Materials and Valproic Acid

Altmetrics

Downloads

95

Views

37

Comments

0

A peer-reviewed article of this preprint also exists.

Submitted:

04 February 2024

Posted:

05 February 2024

You are already at the latest version

Alerts
Abstract
Microplastic pollution represents an emerging problem of great interest in the public domain in the last decade; in addition, it overlaps with another delicate problem - pollution with pharmaceutical products that can have negative effects on the environment and people, even in small amounts. The main purpose of this study was to assess the biochemical and behavioral effects of exposure of adult zebrafish (Danio rerio) to polyethylene (PE), polypropylene (PP) and valproic acid (VPA), respectively to their mixtures - possible situations in natural aquatic environments. In terms of behavioral responses, sociability appears to be more impaired in the PP group after 5 days of exposure. The mechanisms affected are more those of swimming performance than of sociability. Even more, VPA increases presence in the arm with conspecifics but decreases mobility and locomotion, indicating a possible anxiety mechanism. The mixtures decrease the aggressiveness, especially in the case of the PE+VPA group, where it reaches a super low level compared to the control, which could endanger the species in nature. Regarding the anxiogenic effect, PP and PE act differently, if PE has an anxiogenic effect, on the opposite side is the PP group, which shows a bolder and more agitated behavior. All four variants showed behavioral changes indicative of toxicity from the first dose.
Keywords: 
Subject: Biology and Life Sciences  -   Behavioral Sciences

1. Introduction

Plastic pollution has been growing problem in recent years, gaining great public interest [1]. Both terrestrial and aquatic environments are affected by the increase in polymer pollution. Larger plastics gradually degrade into mesoplastics (5-20 mm diameter) and microplastics (<5 mm), which are difficult to degrade naturally [2]. This is an alarming problem for fresh water and sea water as well. Polyethylene and polypropylene are some of the most common plastics found in rivers and oceans. The two types of polymers have applications in both the construction and packaging industries [3].
An additional sensitive issue is pharmaceutical pollution, which may adversely affect the environment and people [4]. Even in small amounts, these pharmaceutical wastes can have a detrimental effect on the environment [5]. Therefore, recent research has focused on the elimination of these contaminants [6]. Nowadays, pharmaceutical residues have started to be monitored due to their presence in wastewater treatment plant effluents and surface waters [7]. A current concern is that some of the active pharmaceutical ingredients partially persist in wastewater treatment processes [8]. The presence of these pharmaceutical substances is due to consumers through the use and disposal of medicines [9]. The use of wastewater for irrigation results in increased pharmaceutical pollution [10].
Valproic acid is the tolerated [11], prescribed medicine for the treatment of epilepsy [12,13], as a mood stabilizer [14,15]. It is also known as a pediatric hepatotoxic agent [16]. VPA is also known to be prescribed to treat affective disorders, spinal muscular atrophy, and headache [17]. Exposure to various environmental chemicals, both in air and in water, has been shown to be a trigger or even a cause of certain neurological disorders, for example, autism spectrum disorder [18]. Valproic acid is one of the pharmaceutical substances presenting an environmental risk in Iraq [19], also reported as high environmental risk in Switzerland since 2010 [20]. Some studies showed that 130 ng L-1 [21], respectively 140 ng L-1 of valproic acid [22] were found in samples from the wastewater influents, taken from the Back River, USA, and from the waste water treatment plant in Baltimore, MD.
The animal model, zebrafish has been gained ground in several fields of research and as a model for complex brain disorders [23]. It has also been used to evaluate the pathological mechanisms of affective disorders [24]. This can be achieved through the zebrafish’s response to different stimuli, which allows researchers to study biological and pharmaceutical processes [25].
The main purpose of this study was to evaluate the individual effects of polyethylene, polypropylene, and valproic acid, at environmentally relevant concentrations [21], and their combined effects on the adult stage of Danio rerio, at behavioral and biochemical levels. We hypothesize that all three contaminants, either alone or in combination, could have a toxicological impact on the zebrafish.

2. Materials and Methods

2.1. Ethical Note

Animals were treated and maintained in accordance with the EU Commission Recommendation (2007), Directive 2010/63/EU of the European Parliament, and Council guidelines of 22 September 2010 on the accommodation, care and protection of animals used for experimental and other scientific purposes. The protocol we followed received approval of the Ethics Commission of the Faculty of Biology, “Alexandru Ioan Cuza” University, Iasi, with registration No. 343/09.02.2023.

2.2. Animal mantainance

For the study we used 30 adult zebrafish (Danio rerio) from an authorized local breeder. The zebrafish used in this experiment had a period under experimental laboratory conditions for 10 days, in 10 L aquariums, equipped with oxygen pumps and water changed daily. After this period, zebrafish were randomly assigned to experimental groups (n= 5).

2.3. Experimental design

Zebrafish were exposed to valproic acid (VPA), polypropylene (PP) and polyethylene (PE) microplastics, respectively combinations of PE+VPA (PEV) and PP+VPA (PPV). The concentrations used were: 2 mg L-1 for the polymeric materials, administered by daily dietary exposure, respectively 25 µM VPA, immersed in the environment for 30 min. The polymeric material was administered for 5 consecutive days, followed by the administration of VPA for 5 days in the specific groups. The diet was in line with the housing and carrying requirements, meaning that 8% of their food weight was administered, combined with the required amount of polymeric material. Behavioral response was analyzed 24 hours after the first dose for all treatments and at the end of the experiment, using the EthoVisionXT 14 video tracking software (Noldus Information Technology, The Netherlands). To observe the joint effects of VPA-polymeric material, the following behavioral tests were used: Novel Tank Test, Social Preference Test and Aggressivity Test. At the end of the experiment, fish were sacrificed according to ethical procedures for the analysis of oxidative stress biomarkers, namely SOD, MDA, GPx and total soluble protein.

2.3.1. Novel Tank Test

The experimental setup consisted of a rectangular tank, filled with 6 liters of water and divided equally into upper and bottom halves. Each fish was placed individually into the tank after the designated treatment periods. To evaluate fish behavior several parameters were assessed using the EthoVision XT software: distance moved, velocity, latency to reach the upper half of the tank, the time spent in the upper half, number of entries into the upper half, inactivity time, and circling behavior. In addition, for a better idea of the level of anxiety, the aquarium, seen from above, was divided into two other areas (peripheral and central). The time spent by the animal in the peripheral zone was used to calculate the anxiety index, according to Freitas et al. 2023 [26]. This index represents the time spent in the peripheral area divided by the total time tested and multiplied by 100. Increased thigmotaxis behavior, usually considered an indicator of anxiety, is associated with the presence of fish in the peripheral zone of the aquarium.

2.3.2. Social Preference Test

The social preference test was performed with a T-maze consisting of two arms (left arm, right arm) and a first arm where the start box is located. The maze is used to study how fish make different choices and behave in different situations, giving the subject a direct choice. To determine social behavior, several conspecifics were placed in a box in the left arm of the maze. The box was created by placing a transparent wall. The tested fish was placed in the start box at the end of the first arm. The frequency and time spent in the left arm of the maze will provide information about the social behavior of the fish, in addition to swimming performance parameters (distance moved, velocity, inactivity time) monitored with EthoVision XT software.

2.3.3. Aggressivity Test

The aggressivity test was performed with a T-maze by closing one arm with a mirror, so that the maze consisted of three arms: one left where the mirror was placed, one right, and a main arm where the start box was located. Each fish spent 4 minutes in the maze where several parameters were analyzed with EthoVision XT software, such as frequency and presence of the fish in the left arm where the mirror is located, swimming bursts, counterclockwise rotations, distance moved and velocity.

2.3.4. Oxidative stress analysis

Following behavioral assessment, all animals were euthanized according to standard laboratory euthanasia procedures by immersion in cold water (2 - 4°C) for at least 10 minutes, until the cessation of opercular movements. The whole fish body was gently homogenized on ice and a tissue extraction buffer was added. The obtained homogenates were then centrifuged at 3500 rpm for 15 min, according to the procedure previously described by our research group [27]. The supernatant was used to determine the enzymatic activities of superoxide dismutase (SOD) and glutathione peroxidase (GPX), and quantify malondialdehyde (MDA) levels. Total soluble protein levels were assessed using Bradford method (Protein Quantification Kit – Rapid (Sigma, Germany)) and were used to calculate the specific activity of antioxidant enzymes (UE/mg TSP) and the relative quantity of MDA (umol/mg TSP). All assays were performed according to the manufacturer’s recommended procedures (SOD Assay Kit (Sigma, Germany), GPx Cellular Activity Assay Kit CGP-1 (Sigma, Germany)). Malondialdehyde (MDA) levels were assessed using the thiobarbituric acid reactive substances (TBARS) method, according to a previously established protocol [28].

2.4. Statistical analysis

Normality and distribution of data were determined by the Shapiro-Wilk test, using Graph Pad Prism software (San Diego, CA, USA). Multiple comparisons between groups were then performed using one-way ANOVA, followed by Tukey’s test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.

3. Results

3.1. Behavior analysis

3.1.1. Novel Tank Test

In PE treatments, distance moved during the tests increased with increasing doses of PE and subsequent doses of VPA, although no statistically significant differences were found (Figure 1, A). The same trend was observed for velocity. However, in this case, the difference between control and PE VPA D5 was statistically significant (p < 0.05, Figure 1, B). No statistically significant differences were found for the time of inactivity (Figure 1, C).
The number of entries in the upper part of the aquarium was surprisingly different. There was a statistically significant value (p < 0.05) between control and PE VPA 24H and p < 0.01 between control and PE VPA D5. Statistically significant differences (p < 005) were also found between PE D5 and PE VPA 24H, respectively (Figure 1, D). Latency to reach the upper half was also highly variable, and statistical differences were found between the control group and PE 24H and PE VPA 24H, respectively (p < 0.05). Other significant differences were found between PE 24H and PE VPA D5, and PE VPA 24H and PE VPA D5 (p < 0.01, Figure 1, E). Time spent in the upper part of the aquarium showed the same increasing trend as distance ed and velocity. A high significant difference was recorded between PE VPA D5 and the other groups (p < 0.001, Figure 1, F). Regarding thigmotaxis, a high significant difference was recorded between the control group and the PE VPA D5 group (p < 0.01, Figure 1, G). The same trend was observed for the anxiety index. There were significant differences between control and PE VPA D5 (p < 0.05, Figure 1, H).
In the PP group, distance moved and velocity decreased over the duration of the tests with administered doses of PP, with subsequent VPA treatments significantly increasing them compared to PP 24H (p < 0.05, Figure 2, A, B). Inactivity time in PP VPA 24H was significantly increased compared to control (p < 0.001) and compared to PP 24H (p < 0.05) (Figure 2, C). The number of entries into the upper part of the aquarium was significantly decreased compared to control (p < 0.001) in PP 24H, PP D5 (p < 0.01) and PP VPA 24H (p < 0.05). There was a significant increase between PP 24H and PP VPA D5 (p < 0.05) (Figure 2, D). For the number of entries into the upper half, there were significant differences between treatments and doses as follows, PP 24H vs. PP VPA 24H (p < 0.01), PP 24H vs. PP VPA D5 (p < 0.05), PP D5 vs. PP VPA 24H (p < 0.001) and PP D5 vs. PP VPA D5 (p < 0.01) (Figure 2, E). The time spent in the upper half was significantly increased in the PP 24H and PP D5 groups, respectively, compared with the control group (p < 0.05, Figure 2, F). Thigmotaxis and anxiety index were variable. Both increased significantly between PP 24h and PP VPA D5 (Figure 2, G, H).

3.1.2. Social Preference Test

Regarding the social preference test in PE treatments, the distance moved decreased, with significant differences between control and PE D5, respectively PE VPA 24H (p < 0.05) and PE VPA D5 (p < 0.01) (Figure 3, A). Velocity significantly decreased in PE VPA D5 compared to control (p < 0.05, Figure 3, B). Inactivity time significantly increased in PE VPA D5 compared to control (p < 0.05, Figure 3, C). The frequency of left arm entry was decreased in PE D5 (p < 0.05) and PE VPA D5, respectively, compared with control (p < 0.01, Figure 3, E). The presence of fish in the left arm with conspecifics was recorded in all treatment cases, with no statistical differences for this parameter (Figure 3, F).
PP treatments showed no significant differences for four out of five parameters monitored: distance moved (Figure 4, A), velocity (Figure 4, B), inactivity time (Figure 4, C) and frequency in the left arm (Figure 4, D). Significant differences were recorded for presence in the left arm, namely control versus PP D5 and PP D5 versus PP VPA 24H (p < 0.05, Figure 4, E).

3.1.3. Aggressivity Test

In the PE treatments, distance moved, and velocity maintained the same decreasing trend of the values recorded during the treatments. There were statistically significant differences between control and PP VPA D5 (p < 0.05, Figure 5, A, B). Presence in the left arm increased significantly in PE D5 compared to control (p < 0.01) and decreased significantly in PE VPA 24H compared to PE D5 (p < 0.05, Figure 5, C). Frequency in the left arm significantly increased in PE D5 compared to control (p < 0.05) and significantly decreased in PE VPA D5 compared to PE D5 (p < 0.05, Figure 5, D). The swim burst significantly decreased in PE VPA D5 compared to the control and in PE 24H (p < 0.05, Figure 5, E). Counterclockwise rotations significantly increased in PE D5 vs. control (p < 0.01) and vs. PE 24H (p < 0.001). Significant decreases after VPA treatments were observed between PE D5 vs. PE VPA 24H and PE VPA D5, respectively (p < 0.001, Figure 5, F).
PP treatments showed no significant differences for four out of five parameters monitored: distance moved (Figure 6, A), velocity (Figure 6, B), presence in the left arm (Figure 6, C), and swim burst (Figure 4, E). Significant differences were observed for left arm frequency, namely between control and PP VPA D5 (p < 0.05, Figure 6, D). For the counterclockwise rotations, significant increases were registered as follows: control vs. PP 24H (p < 0.05), control vs. PP VPA 24H (p < 0.01), and PP D5 vs. PP VPA 24H (p < 0.05, Figure 6, F).

3.2. Oxidative stress analysis

We found a suggestive increased specific SOD activity following exposure to PE and PPV compared to the control group. Significant difference was found in the following situations: PP vs. PE (p < 0.05), PP vs. PPV (p < 0.05), PE vs. PEV (p < 0.05), VPA vs. PPV (p < 0.05), PPV vs. PEV (p < 0.05) (Figure 7, A). Regarding the antioxidant activity of GPx, we observed that it was significantly lower after exposure to PE compared to the control group (p < 0.01). Another significant difference was found between PP vs. PE (p < 0.01) and PE vs. VPA (p < 0.05, Figure 7, B). In general, we observed that MDA levels increased following treatments, compared to controls, except for VPA exposure which resulted in the opposite effect. Statistically significant changes in MDA content were observed for CTR vs. PPV (p < 0.01), PP vs. VPA (p < 0.01), PP vs. PPV (p < 0.05), VPA vs. PEV (p < 0.05), VPA vs. PPV (p < 0.001) comparisons (Figure 7, C).

4. Discussion

Danio rerio has been established as a suitable animal model for pharmaceutical studies [29], especially due to the possibility of immersion in water of the investigated substances and the high potential of zebrafish to absorb these compounds [30]. Zebrafish has proven to be an excellent tool due to its high genetic similarity to humans [31], thus motivating the study of some human diseases using the Danio rerio animal model. In this sense, the zebrafish is an appropriate model for biomedical research [32]. Due to the behavioral characteristics, and homology observed with humans with autism spectrum disorder (ASD), the zebrafish is also a relevant model for the study this disease [29]. Studies have shown that VPA can induce ASD- like symptom behavior in zebrafish juvenile at a concentration of 48 µM VPA [33]. This applies to both larval and adult zebrafish [34]. Other studies have shown that valproic acid can negatively affect embryonic vasculature from exposure concentrations starting at 2.5 μM [35] but can also affect larval social behavior [36]. Exposure between 0.33 and 4.5 days post-fertilization (dpf) to 10 μM VPA was identified as an effective concentration to induce an early and persistent ASD-like phenotype in zebrafish, as embryonic exposure to VPA also reduces survival, induces malformations and delays hatching in a dose- and time-dependent manner, also triggering hyperactivity, anxiety-like behavior and social deficits [34].
Regarding plastic pollution, limiting the flow of plastic from rivers to marine ecosystems is an important part of reducing the amount of plastic in the environment [37]. The spread of polymers in both rivers and oceans can be stopped by effective management that removes plastics directly from their source. Plastic pollution has become a major environmental concern due to its extensive use and fast spread [38]). Microplastics in freshwater ecosystems and marine environments can cause both physical and histological damage [39]. Even more, PE and PP, are the most common plastics found in the marine environment [40].
In terms of behavior analysis, in the case of the Novel Tank test, considering the distance moved and velocity, in the case of the PE-VPA treatments, PE has an anxiolytic effect immediately after the first dose, and it increases with the dose. The treatment with VPA increased an anxiogenic effect from the first dose and by day five, especially by the increased inactivity time. The latency to reach the upper part of the aquarium is lower after the first dose of PE treatment and then increases with the number of doses, with fish preferring the upper part of the aquarium, especially after VPA administration. In the case of PP-VPA treatments, PP induces opposite behavior to PE. Thus, from the first dose of PP, the fish prefer the upper part of the aquarium. This trend is maintained until the 5th dose of PP. This also holds true when treated with VPA.
In the case of PE we noticed that starting from the first dose of VPA, the latency decreased and the fish explored the entire aquarium again. However, at the first dose of PE and at the 5th dose of VPA thigmotaxis was most pronounced. In the case of PP, the thigmotaxis is more evident only at the 5th dose and is maintained during VPA treatment. VPA treatment significantly increases the total exploratory capacity expressed by the distance moved of the fish.
Anxiety-like behavior was triggered in different studies, for example in rats exposed to 600 mg kg-1 VPA [41] or 70 dpf zebrafish exposed to 48 µM VPA [32]. The most obvious results were observed when analyzing the sociability test. The first dose of PE increased the presence of fish close to conspecifics. This presence began to decrease over the course of treatment. In the case of the first VPA treatment, the presence of fish near conspecifics is much higher and maintains an upward trend until the 5th day of treatment. During both treatments, distance moved and velocity were steadily decreasing. Regarding social preference, as in the case of PE, the plastic treatment decreases sociability until the 5th day. However, VPA has a great influence, so that from the first day of treatment with VPA, the presence of fish is majority in the arm where the conspecifics are located. Sociability is more affected at the fifth dose of PP. In this case, the affected mechanisms are more related to swimming performance.
In our study, VPA does not induce social impairments or hyperactivity deficits [34] or other ASD-like events. VPA increases presence in the left arm but also increases inactivity time, indicating a possible anxiety mechanism. When testing aggressiveness, velocity and distance moved show similar trends. In the case of the first dose of PE they continue to decrease until the fifth dose. The first dose of VPA produces a slight increase in these two parameters, but by the 5th dose both decrease to almost half of the control value. On the other hand, the first dose of PE induces more aggressive behavior compared to the control with an increasing trend up to the 5th dose. In the case of PP, total distance moved and velocity decreased first and started to increase during VPA treatments. The presence of fish near the mirror is higher from the first day of treatment with PP and is maintained until the 5th day of treatment with VPA. The first dose of VPA increased this presence. However, it decreased in direct proportion to the increase in dose. For the PE group, the first dose of VPA significantly decreases the presence of fish near the mirror, but by day 5, this presence increases again. Also, counterclockwise rotations, which are a marker of aggressiveness [27], were observed with a high frequency compared to the control group in the first 24 hours after PP treatment and at 24 hours after VPA treatment, reaching limits significantly lower until the 5th day of treatment. Significant results were obtained in the PE-VPA treatments. In the PE group, highest increase was observed on day 5, while the other groups maintained the same frequency as the control group. This reinforces the idea that PE has an anxiogenic effect on fish behavior. The frequency of swim bursts decreases with the PP treatments and increases with the VPA treatment. In this case, PP produces a non-aggressive behavior, but the situation changes radically from the first dose of VPA. Moreover, the frequency of swim bursts was lower at the 5th dose of PE compared to the first, but treatment with VPA decreases this frequency by the 5th dose.
It is worth noting that in the case of VPA treatments, behavioral differences appear with increasing doses [32,34,42]. In the case of our study, the administration of VPA after intoxication with polymeric materials indicates the same thing, especially since depending on the polymeric material in some cases the first dose is the one that alleviates the effects and then they worsen, or only the fifth dose is the one that helps. In this regard, if VPA can be used for the treatment of polymer intoxication, it is important to know what the purpose of VPA administration would be. However, in the case of exposure to these pollutants under the conditions simulated in this study, the effects are visible and have a negative impact.
Superoxide dismutase (SOD) is an antioxidant enzyme that plays a critical role in the neutralizing superoxide radicals, being the first antioxidant enzyme within cellular the enzymatic defense against oxidative stress. It is currently thought that increased levels of SOD are the results of an adaptive mechanism that counteracts the pro-oxidative status and thus protects cells from potential damage. This response is often seen in a variety of physiological or pathological conditions where increased production of reactive oxygen species occurs [43]. In our study, we observed increased levels of SOD following PE and PP+VPA exposure. Other studies have shown significantly increased levels of SOD and decreased levels of GPx in the liver of adult zebrafish exposed to PP for 21 consecutive days [43]. However, no significant changes were observed in the brain of exposed fish [44]. Lower levels of GPx may indicate a reduced ability to neutralize free radicals, which may make cells more susceptible to oxidative damage. This may be associated with increased oxidative stress, which has been implicated in several health problems, including chronic inflammation, neurodegenerative disease, and cardiovascular disease [45]. In our study, lower levels of GPx were found in the PE group. Similarly, a 96-hour exposure to PE beads of different sizes reduced GPx activity in the brain and liver of adult zebrafish [46]. Elevated levels of malondialdehyde (MDA) are often considered a marker of lipid peroxidation. MDA indicates oxidative damage to cell membranes. Elevated MDA levels may be associated with increased oxidative stress. MDA has been implicated in several health conditions, including inflammation, cardiovascular disease, and neurodegenerative disorders [47]. In our study, all groups except VPA showed a high level of MDA compared to the control group. PP significantly elevated malondialdehyde (MDA) levels in the stomach in a 28-day study on male zebrafish. Moreover, combination of triclosan and PP significantly aggravated oxidative stress and lipid peroxidation in the liver as well as has enhanced neurotoxicity in the brain [48]. In another 21-day study, PP-MPs resulted in increased levels of MDA in gills and liver cells compared to controls, indicating a dose-dependent effect [49]. In our study, only VPA was shown to lower MDA levels, similar to another study that also found lower MDA levels when adult zebrafish were exposed to 0.5 mg mL-1 VPA. Furthermore, compared to either substance alone, the combination of rotenone and VPA showed an increased level of MDA [27]. The same was found when we combined PP and VPA.

5. Conclusions

In conclusion, the two types of plastic have very different effects: PE induces anxious behavior, while PP induces hyperactive behavior. Regarding aggressive behavior, PE treatment resulted in an increased manifestation of this behavioral trait compared to PP treatment. Conversely, an increased level of aggressive behavior was observed when VPA was administered. Sociability is the parameter most affected by the presence of polymers, both of which produce antisocial behavior. Both treatment groups show an evident social preference. However, a possible anxiety mechanism is actually hidden, especially due to increased inactivity time and influence on swimming performance from the first dose of VPA administrated. All three pollutants, alone or in cocktail, had a marked influence on GPx and MDA in terms of oxidative stress. In light of all the results of our study, our hypothesis has been confirmed.
However, future research is needed on both the negative effects of the toxic cocktail and the potential of VPA to mitigate the negative effects of microplastics toxicity.

Author Contributions

Conceptualization, methodology, software, writing—original draft preparation A.S., I.A.C., investigation A.S., A.S.C., I..B.M and I.A.C., writing—review and editing, visualization, supervision A.C. and M.N.N.

Funding

This research received no external funding.

Institutional Review Board Statement

The animal study protocol was approved by the Institutional Ethics Committee of the Faculty of Biology, “Alexandru Ioan Cuza” University, Iasi with No. 343/09.02.2023.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Henderson, L.; Green, C. Making Sense of Microplastics? Public Understandings of Plastic Pollution. Mar Pollut Bull 2020, 152, 110908. [Google Scholar] [CrossRef]
  2. Zhang, B.; Chen, L.; Chao, J.; Yang, X.; Wang, Q. Research Progress of Microplastics in Freshwater Sediments in China. Environmental Science and Pollution Research 2020, 27, 31046–31060. [Google Scholar] [CrossRef]
  3. Nanthini Devi, K.; Raju, P.; Santhanam, P.; Dinesh Kumar, S.; Krishnaveni, N.; Roopavathy, J.; Perumal, P. Biodegradation of Low-Density Polyethylene and Polypropylene by Microbes Isolated from Vaigai River, Madurai, India. Arch Microbiol 2021, 203, 6253–6265. [Google Scholar] [CrossRef]
  4. Wilkinson, J.L.; Boxall, A.B.A.; Kolpin, D.W.; Leung, K.M.Y.; Lai, R.W.S.; Galbán-Malagón, C.; Adell, A.D.; Mondon, J.; Metian, M.; Marchant, R.A.; et al. Pharmaceutical Pollution of the World’s Rivers. Proceedings of the National Academy of Sciences 2022, 119. [Google Scholar] [CrossRef]
  5. Desai, M.; Njoku, A.; Nimo-Sefah, L. Comparing Environmental Policies to Reduce Pharmaceutical Pollution and Address Disparities. Int J Environ Res Public Health 2022, 19, 8292. [Google Scholar] [CrossRef] [PubMed]
  6. Onesios-Barry, K.M.; Berry, D.; Proescher, J.B.; Sivakumar, I.K.A.; Bouwer, E.J. Removal of Pharmaceuticals and Personal Care Products during Water Recycling: Microbial Community Structure and Effects of Substrate Concentration. Appl Environ Microbiol 2014, 80, 2440–2450. [Google Scholar] [CrossRef]
  7. Quesada, H.B.; Baptista, A.T.A.; Cusioli, L.F.; Seibert, D.; de Oliveira Bezerra, C.; Bergamasco, R. Surface Water Pollution by Pharmaceuticals and an Alternative of Removal by Low-Cost Adsorbents: A Review. Chemosphere 2019, 222, 766–780. [Google Scholar] [CrossRef] [PubMed]
  8. Klimaszyk, P.; Rzymski, P. Water and Aquatic Fauna on Drugs: What Are the Impacts of Pharmaceutical Pollution? In; 2018; pp. 255–278. [CrossRef]
  9. Vatovec, C.; Van Wagoner, E.; Evans, C. Investigating Sources of Pharmaceutical Pollution: Survey of over-the-Counter and Prescription Medication Purchasing, Use, and Disposal Practices among University Students. J Environ Manage 2017, 198, 348–352. [Google Scholar] [CrossRef] [PubMed]
  10. Anjanapriya, S.; SulaimanMumtaz, M.; Mohideen, M.H.A.K.; Radha, A.; Sasirekha, N.; Sawicka, B.; Tamizhazhagan, V. Pharmaceutical Pollution Crisis in the World: A Menace to Ecosystem. Entomology and Applied Science Letters 2021, 8, 77–89. [Google Scholar] [CrossRef]
  11. Hsu, H.-C.; Tseng, H.-K.; Wang, S.-C.; Wang, Y.-Y. Valproic Acid-Induced Agranulocytosis. Int J Gerontol 2009, 3, 137–139. [Google Scholar] [CrossRef]
  12. Terbach, N.; Shah, R.; Kelemen, R.; Klein, P.S.; Gordienko, D.; Brown, N.A.; Wilkinson, C.J.; Williams, R.S.B. Identifying an Uptake Mechanism for the Antiepileptic and Bipolar Disorder Treatment Valproic Acid Using the Simple Biomedical Model Dictyostelium. J Cell Sci 2011, 124, 2267–2276. [Google Scholar] [CrossRef]
  13. Triyasakorn, K.; Ubah, U.D.B.; Roan, B.; Conlin, M.; Aho, K.; Awale, P.S. The Antiepileptic Drug and Toxic Teratogen Valproic Acid Alters Microglia in an Environmental Mouse Model of Autism. Toxics 2022, 10, 379. [Google Scholar] [CrossRef] [PubMed]
  14. Lee, Y.; Kim, Y.-H.; Yun, J.-S.; Lee, C.-J. Valproic Acid Decreases the Proliferation of Telencephalic Cells in Zebrafish Larvae. Neurotoxicol Teratol 2013, 39, 91–99. [Google Scholar] [CrossRef] [PubMed]
  15. Kus, K.; Burda, K.; Nowakowska, E.; Czubak, A.; Metelska, J.; Łancucki, M.; Brodowska, K.; Nowakowska, A. Effect of Valproic Acid and Environmental Enrichment on Behavioral Functions in Rats. Arzneimittelforschung 2011, 60, 471–478. [Google Scholar] [CrossRef] [PubMed]
  16. Brotzmann, K.; Escher, S.E.; Walker, P.; Braunbeck, T. Potential of the Zebrafish (Danio Rerio) Embryo Test to Discriminate between Chemicals of Similar Molecular Structure—a Study with Valproic Acid and 14 of Its Analogues. Arch Toxicol 2022, 96, 3033–3051. [Google Scholar] [CrossRef] [PubMed]
  17. Romoli, M.; Mazzocchetti, P.; D’Alonzo, R.; Siliquini, S.; Rinaldi, V.E.; Verrotti, A.; Calabresi, P.; Costa, C. Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences. Curr Neuropharmacol 2019, 17, 926–946. [Google Scholar] [CrossRef]
  18. Lee, S.; Chun, H.-S.; Lee, J.; Park, H.-J.; Kim, K.-T.; Kim, C.-H.; Yoon, S.; Kim, W.-K. Plausibility of the Zebrafish Embryos/Larvae as an Alternative Animal Model for Autism: A Comparison Study of Transcriptome Changes. PLoS One 2018, 13, e0203543. [Google Scholar] [CrossRef]
  19. Al-Khazrajy, O.S.A.; Boxall, A.B.A. Risk-Based Prioritization of Pharmaceuticals in the Natural Environment in Iraq. Environmental Science and Pollution Research 2016, 23, 15712–15726. [Google Scholar] [CrossRef]
  20. Perazzolo, C.; Morasch, B.; Kohn, T.; Magnet, A.; Thonney, D.; Chèvre, N. Occurrence and Fate of Micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part I: Priority List for Environmental Risk Assessment of Pharmaceuticals. Environ Toxicol Chem 2010, 29, 1649–1657. [Google Scholar] [CrossRef]
  21. Yu, J.T.; Bisceglia, K.J.; Bouwer, E.J.; Roberts, A.L.; Coelhan, M. Determination of Pharmaceuticals and Antiseptics in Water by Solid-Phase Extraction and Gas Chromatography/Mass Spectrometry: Analysis via Pentafluorobenzylation and Stable Isotope Dilution. Anal Bioanal Chem 2012, 403, 583–591. [Google Scholar] [CrossRef]
  22. Yu, J.T.; Bouwer, E.J.; Coelhan, M. Occurrence and Biodegradability Studies of Selected Pharmaceuticals and Personal Care Products in Sewage Effluent. Agric Water Manag 2006, 86, 72–80. [Google Scholar] [CrossRef]
  23. Collier, A.D.; Khan, K.M.; Caramillo, E.M.; Mohn, R.S.; Echevarria, D.J. Zebrafish and Conditioned Place Preference: A Translational Model of Drug Reward. Prog Neuropsychopharmacol Biol Psychiatry 2014, 55, 16–25. [Google Scholar] [CrossRef]
  24. de Abreu, M.S.; Costa, F.; Giacomini, A.C.V. V.; Demin, K.A.; Zabegalov, K.N.; Maslov, G.O.; Kositsyn, Y.M.; Petersen, E.V.; Strekalova, T.; Rosemberg, D.B.; et al. Towards Modeling Anhedonia and Its Treatment in Zebrafish. International Journal of Neuropsychopharmacology 2022, 25, 293–306. [Google Scholar] [CrossRef]
  25. Cueto-Escobedo, J.; German-Ponciano, L.J.; Guillén-Ruiz, G.; Soria-Fregozo, C.; Herrera-Huerta, E.V. Zebrafish as a Useful Tool in the Research of Natural Products With Potential Anxiolytic Effects. Front Behav Neurosci 2022, 15. [Google Scholar] [CrossRef]
  26. Freitas, Í.N.; Dourado, A.V.; Araújo, A.P.d.C.; de Souza, S.S.; da Luz, T.M.; Guimarães, A.T.B.; Gomes, A.R.; Islam, A.R.M.T.; Rahman, M.M.; Arias, A.H.; et al. Toxicity Assessment of SARS-CoV-2-Derived Peptides in Combination with a Mix of Pollutants on Zebrafish Adults: A Perspective Study of Behavioral, Biometric, Mutagenic, and Biochemical Toxicity. Science of The Total Environment 2023, 858, 159838. [Google Scholar] [CrossRef]
  27. Ilie, O.-D.; Duta, R.; Jijie, R.; Nita, I.-B.; Nicoara, M.; Faggio, C.; Dobrin, R.; Mavroudis, I.; Ciobica, A.; Doroftei, B. Assessing Anti-Social and Aggressive Behavior in a Zebrafish (Danio Rerio) Model of Parkinson’s Disease Chronically Exposed to Rotenone. Brain Sci 2022, 12, 898. [Google Scholar] [CrossRef] [PubMed]
  28. Balmus, I.-M.; Lefter, R.; Ciobica, A.; Cojocaru, S.; Guenne, S.; Timofte, D.; Stanciu, C.; Trifan, A.; Hritcu, L. Preliminary Biochemical Description of Brain Oxidative Stress Status in Irritable Bowel Syndrome Contention-Stress Rat Model. Medicina (B Aires) 2019, 55, 776. [Google Scholar] [CrossRef] [PubMed]
  29. Meshalkina, D.A.; Kizlyk, M.N.; Kysil, E.V.; Collier, A.D.; Echevarria, D.J.; Abreu, M.S.; Barcellos, L.J.G.; Song, C.; Warnick, J.E.; Kyzar, E.J.; et al. Zebrafish Models of Autism Spectrum Disorder. Exp Neurol 2018, 299, 207–216. [Google Scholar] [CrossRef]
  30. Goldsmith, P. Zebrafish as a Pharmacological Tool: The How, Why and When. Curr Opin Pharmacol 2004, 4, 504–512. [Google Scholar] [CrossRef] [PubMed]
  31. Belo, M.A.A.; Oliveira, M.F.; Oliveira, S.L.; Aracati, M.F.; Rodrigues, L.F.; Costa, C.C.; Conde, G.; Gomes, J.M.M.; Prata, M.N.L.; Barra, A.; et al. Zebrafish as a Model to Study Inflammation: A Tool for Drug Discovery. Biomedicine & Pharmacotherapy 2021, 144, 112310. [Google Scholar] [CrossRef]
  32. Zimmermann, F.F.; Gaspary, K.V.; Leite, C.E.; De Paula Cognato, G.; Bonan, C.D. Embryological Exposure to Valproic Acid Induces Social Interaction Deficits in Zebrafish (Danio Rerio): A Developmental Behavior Analysis. Neurotoxicol Teratol 2015, 52, 36–41. [Google Scholar] [CrossRef] [PubMed]
  33. Robea, M.A.; Ciobica, A.; Curpan, A.-S.; Plavan, G.; Strungaru, S.; Lefter, R.; Nicoara, M. Preliminary Results Regarding Sleep in a Zebrafish Model of Autism Spectrum Disorder. Brain Sci 2021, 11, 556. [Google Scholar] [CrossRef] [PubMed]
  34. Joseph, T.P.; Zhou, F.; Sai, L.Y.; Chen, H.; Lin, S.L.; Schachner, M. Duloxetine Ameliorates Valproic <scp>acid-induced</Scp> Hyperactivity, Anxiety-like Behavior, and Social Interaction Deficits in Zebrafish. Autism Research 2022, 15, 27–41. [Google Scholar] [CrossRef]
  35. Li, L.; Bonneton, F.; Tohme, M.; Bernard, L.; Chen, X.Y.; Laudet, V. In Vivo Screening Using Transgenic Zebrafish Embryos Reveals New Effects of HDAC Inhibitors Trichostatin A and Valproic Acid on Organogenesis. PLoS One 2016, 11, e0149497. [Google Scholar] [CrossRef]
  36. Bailey, J.M.; Oliveri, A.N.; Karbhari, N.; Brooks, R.A.J.; De La Rocha, A.J.; Janardhan, S.; Levin, E.D. Persistent Behavioral Effects Following Early Life Exposure to Retinoic Acid or Valproic Acid in Zebrafish. Neurotoxicology 2016, 52, 23–33. [Google Scholar] [CrossRef] [PubMed]
  37. Helinski, O.K.; Poor, C.J.; Wolfand, J.M. Ridding Our Rivers of Plastic: A Framework for Plastic Pollution Capture Device Selection. Mar Pollut Bull 2021, 165, 112095. [Google Scholar] [CrossRef] [PubMed]
  38. Wang, Y.; Shi, H.; Li, T.; Yu, L.; Qi, Y.; Tian, G.; He, F.; Li, X.; Sun, N.; Liu, R. Size-Dependent Effects of Nanoplastics on Structure and Function of Superoxide Dismutase. Chemosphere 2022, 309, 136768. [Google Scholar] [CrossRef]
  39. Ding, R.; Tong, L.; Zhang, W. Microplastics in Freshwater Environments: Sources, Fates and Toxicity. Water Air Soil Pollut 2021, 232, 181. [Google Scholar] [CrossRef]
  40. Karuppasamy, P.K.; Ravi, A.; Vasudevan, L.; Elangovan, M.P.; Dyana Mary, P.; Vincent, S.G.T.; Palanisami, T. Baseline Survey of Micro and Mesoplastics in the Gastro-Intestinal Tract of Commercial Fish from Southeast Coast of the Bay of Bengal. Mar Pollut Bull 2020, 153, 110974. [Google Scholar] [CrossRef]
  41. Olexová, L.; Štefánik, P.; Kršková, L. Increased Anxiety-like Behaviour and Altered GABAergic System in the Amygdala and Cerebellum of VPA Rats—An Animal Model of Autism. Neurosci Lett 2016, 629, 9–14. [Google Scholar] [CrossRef]
  42. Liu, X.; Zhang, Y.; Lin, J.; Xia, Q.; Guo, N.; Li, Q. Social Preference Deficits in Juvenile Zebrafish Induced by Early Chronic Exposure to Sodium Valproate. Front Behav Neurosci 2016, 10. [Google Scholar] [CrossRef]
  43. Younus, H. Therapeutic Potentials of Superoxide Dismutase. Int J Health Sci (Qassim) 2018, 12, 88–93. [Google Scholar]
  44. Félix, L.; Carreira, P.; Peixoto, F. Effects of Chronic Exposure of Naturally Weathered Microplastics on Oxidative Stress Level, Behaviour, and Mitochondrial Function of Adult Zebrafish (Danio Rerio). Chemosphere 2023, 310, 136895. [Google Scholar] [CrossRef] [PubMed]
  45. Lubos, E.; Loscalzo, J.; Handy, D.E. Glutathione Peroxidase-1 in Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities. Antioxid Redox Signal 2011, 15, 1957. [Google Scholar] [CrossRef]
  46. Mak, C.W.; Ching-Fong Yeung, K.; Chan, K.M. Acute Toxic Effects of Polyethylene Microplastic on Adult Zebrafish. Ecotoxicol Environ Saf 2019, 182, 109442. [Google Scholar] [CrossRef]
  47. Del Rio, D.; Stewart, A.J.; Pellegrini, N. A Review of Recent Studies on Malondialdehyde as Toxic Molecule and Biological Marker of Oxidative Stress. Nutr Metab Cardiovasc Dis 2005, 15, 316–328. [Google Scholar] [CrossRef]
  48. Sheng, C.; Zhang, S.; Zhang, Y. The Influence of Different Polymer Types of Microplastics on Adsorption, Accumulation, and Toxicity of Triclosan in Zebrafish. J Hazard Mater 2021, 402, 123733. [Google Scholar] [CrossRef] [PubMed]
  49. Bobori, D.C.; Feidantsis, K.; Dimitriadi, A.; Datsi, N.; Ripis, P.; Kalogiannis, S.; Sampsonidis, I.; Kastrinaki, G.; Ainali, N.M.; Lambropoulou, D.A.; et al. Dose-Dependent Cytotoxicity of Polypropylene Microplastics (PP-MPs) in Two Freshwater Fishes. Int J Mol Sci 2022, 23, 13878. [Google Scholar] [CrossRef] [PubMed]
Preprints 98161 g001
Figure 1. Graphical representation of behavior patterns in PE and PEV treatments in the Novel Tank Test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.
Figure 1. Graphical representation of behavior patterns in PE and PEV treatments in the Novel Tank Test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.
Preprints 98161 g001
Preprints 98161 g002
Figure 2. Graphical representation of behavior patterns in PP and PPV treatments in the Novel Tank Test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.
Figure 2. Graphical representation of behavior patterns in PP and PPV treatments in the Novel Tank Test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.
Preprints 98161 g002
Preprints 98161 g003
Figure 3. Graphical representation of behavior patterns in PE and PEV treatments in the Social Preference Test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.
Figure 3. Graphical representation of behavior patterns in PE and PEV treatments in the Social Preference Test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.
Preprints 98161 g003
Preprints 98161 g004
Figure 4. Graphical representation of behavior patterns in PP and PPV treatments in the Social Preference Test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.
Figure 4. Graphical representation of behavior patterns in PP and PPV treatments in the Social Preference Test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.
Preprints 98161 g004
Preprints 98161 g005
Figure 5. Graphical representation of behavior patterns in PE and PEV treatments in Aggressivity Test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.
Figure 5. Graphical representation of behavior patterns in PE and PEV treatments in Aggressivity Test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.
Preprints 98161 g005
Preprints 98161 g006
Figure 6. Graphical representation of behavior patterns in PP and PPV treatments in Aggressivity Test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.
Figure 6. Graphical representation of behavior patterns in PP and PPV treatments in Aggressivity Test. Data are expressed as mean ± SEM, and a p < 0.05 was considered statistically significant.
Preprints 98161 g006
Preprints 98161 g007
Figure 7. Graphical representation of the levels of oxidative stress markers: SOD specific activity (UE SOD/ mg TSP) (A), GPx specific activity (mUE GPx/ mg TSP) (B), and MDA relative content (umol MDA/ mg TSP) (C). Data were expressed as mean ± SEM (n = 5/ per group, *p < 0.05, **p < 0.01, ***p < 0.001 in two-tailed t-test). TSP = total soluble proteins.
Figure 7. Graphical representation of the levels of oxidative stress markers: SOD specific activity (UE SOD/ mg TSP) (A), GPx specific activity (mUE GPx/ mg TSP) (B), and MDA relative content (umol MDA/ mg TSP) (C). Data were expressed as mean ± SEM (n = 5/ per group, *p < 0.05, **p < 0.01, ***p < 0.001 in two-tailed t-test). TSP = total soluble proteins.
Preprints 98161 g007
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated